Trials / Recruiting
RecruitingNCT06445088
Diagnostic Accuracy of EBV C Promoter Methylation Kit in Nasopharyngeal Carcinoma
Evaluation of Diagnostic Performance of a Detection Kit for Epstein-Barr Virus C Promoter Methylation in Nasopharyngeal Carcinoma
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 908 (estimated)
- Sponsor
- Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This clinical study aims to evaluate the diagnostic performance of a new Epstein-Barr virus (EBV) C promoter methylation detection kit. All participants will undergo a series of diagnostic tests including VCA-IgA, EBNA1-IgA, and EBV-DNA assays. Additionally, nasopharyngeal swabs will be analyzed for EBV C promoter methylation. Confirmatory biopsy will be performed on all patients to establish a definitive diagnosis. This comprehensive approach seeks to assess the effectiveness of the methylation detection kit in a clinical setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | VCA-IgA, EBNA1-IgA, and EBV-DNA | Detect VCA-IgA, EBNA1-IgA, and EBV-DNA for all participants. |
| DIAGNOSTIC_TEST | EBV C Promoter Methylation Detection in nasopharyngeal swab samples | Detection of methylation status of Epstein-Barr virus C promoter in human nasopharyngeal swab samples |
Timeline
- Start date
- 2024-05-29
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2024-06-06
- Last updated
- 2024-06-25
Locations
5 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06445088. Inclusion in this directory is not an endorsement.